Illumina Inc. launched the next generation of its distributed liquid biopsy assay for genomic profiling. The updated Trusight Oncology (TSO) ctDNA v2, currently available for research use only, allows comprehensive genomic profiling (CGP) of circulating tumor DNA with only a blood sample.